Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +55.02%
#2 Pons Pons +46.41%
#3 TENDIES TENDIES +40.12%
#4 PondCoin PondCoin +34.70%
#5 Magma Finance Magma Finance +33.49%
#6 Purr Purr +30.11%
#7 The Bitcoin Bull The Bitcoin Bull +28.85%
#8 StonkBroker StonkBroker +28.68%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
#10 SkyAI SkyAI +26.65%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Classement en actions #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Prix de l'action
$0.07339369
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$25.24M
Changement (1 jour)
5.26%
Changement (1 an)
-9.55%
Pays
CA
Échange Resverlogix Corp. (RVX)

Catégorie

Healthcare
Bénéfices pour Resverlogix Corp. (RVX)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Resverlogix Corp., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Resverlogix Corp. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH